| Ann Tran, | |
|
27 Barker Ave Apt 404, White Plains, NY 10601-1559 | |
| (917) 929-1468 | |
| Not Available |
| Full Name | Ann Tran |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 12 Years |
| Location | 27 Barker Ave Apt 404, White Plains, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578839676 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VF0040X | Obstetrics & Gynecology - Female Pelvic Medicine And Reconstructive Surgery | 282187 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Sinai Beth Israel | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Icahn School Of Medicine At Mount Sinai | 2264691070 | 2339 |
News Archive
The Duke study showed that, for a sample of white middle-aged women, as body mass index (BMI) went up, the odds of receiving mammograms and Pap smears went down.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with PharmAbcine, Inc. for the development, manufacturing and marketing of Tanibirumab, an anti-VEGFR2/KDR antibody for cancer in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and several emerging countries, including Thailand, Brazil and Russia.
Virtual reality technology gives high school students greater insight into what it's like to be Alfred - a 74-year-old African American man with suspected mild cognitive impairment, plus age-related vision and hearing loss, or Beatriz, a middle-aged Latina, as she progresses through the continuum of Alzheimer's disease.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
› Verified 4 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124392212 PECOS PAC ID: 2264691070 Enrollment ID: O20120910000003 |
News Archive
The Duke study showed that, for a sample of white middle-aged women, as body mass index (BMI) went up, the odds of receiving mammograms and Pap smears went down.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with PharmAbcine, Inc. for the development, manufacturing and marketing of Tanibirumab, an anti-VEGFR2/KDR antibody for cancer in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and several emerging countries, including Thailand, Brazil and Russia.
Virtual reality technology gives high school students greater insight into what it's like to be Alfred - a 74-year-old African American man with suspected mild cognitive impairment, plus age-related vision and hearing loss, or Beatriz, a middle-aged Latina, as she progresses through the continuum of Alzheimer's disease.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
› Verified 4 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770823551 PECOS PAC ID: 2264691070 Enrollment ID: O20131220001018 |
News Archive
The Duke study showed that, for a sample of white middle-aged women, as body mass index (BMI) went up, the odds of receiving mammograms and Pap smears went down.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with PharmAbcine, Inc. for the development, manufacturing and marketing of Tanibirumab, an anti-VEGFR2/KDR antibody for cancer in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and several emerging countries, including Thailand, Brazil and Russia.
Virtual reality technology gives high school students greater insight into what it's like to be Alfred - a 74-year-old African American man with suspected mild cognitive impairment, plus age-related vision and hearing loss, or Beatriz, a middle-aged Latina, as she progresses through the continuum of Alzheimer's disease.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
› Verified 4 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467865063 PECOS PAC ID: 2264691070 Enrollment ID: O20141015000525 |
News Archive
The Duke study showed that, for a sample of white middle-aged women, as body mass index (BMI) went up, the odds of receiving mammograms and Pap smears went down.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with PharmAbcine, Inc. for the development, manufacturing and marketing of Tanibirumab, an anti-VEGFR2/KDR antibody for cancer in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and several emerging countries, including Thailand, Brazil and Russia.
Virtual reality technology gives high school students greater insight into what it's like to be Alfred - a 74-year-old African American man with suspected mild cognitive impairment, plus age-related vision and hearing loss, or Beatriz, a middle-aged Latina, as she progresses through the continuum of Alzheimer's disease.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ann Tran, 27 Barker Ave, Apt 216, White Plains, NY 10601-1553 Ph: () - | Ann Tran, 27 Barker Ave Apt 404, White Plains, NY 10601-1559 Ph: (917) 929-1468 |
News Archive
The Duke study showed that, for a sample of white middle-aged women, as body mass index (BMI) went up, the odds of receiving mammograms and Pap smears went down.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with PharmAbcine, Inc. for the development, manufacturing and marketing of Tanibirumab, an anti-VEGFR2/KDR antibody for cancer in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and several emerging countries, including Thailand, Brazil and Russia.
Virtual reality technology gives high school students greater insight into what it's like to be Alfred - a 74-year-old African American man with suspected mild cognitive impairment, plus age-related vision and hearing loss, or Beatriz, a middle-aged Latina, as she progresses through the continuum of Alzheimer's disease.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
› Verified 4 days ago
Juan Carlos Rojas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12 Greenridge Ave, Suite 302, White Plains, NY 10605 Phone: 914-937-6085 Fax: 914-934-3253 | |
Subodh K Datta, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 Tarrytown Rd, White Plains, NY 10607 Phone: 914-989-7600 Fax: 914-285-4991 | |
Dr. Aurora Leibold, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-682-0732 | |
Dr. Rebecca Ann Kleban, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-831-6800 Fax: 914-831-6801 | |
Dr. Fernando Temporal Mariz, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 222 Mamaroneck Ave, White Plains, NY 10605 Phone: 914-946-0050 | |
Dr. Janice Renee Crowder, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 41 E Post Rd, White Plains, NY 10601 Phone: 914-681-0600 Fax: 914-681-2912 | |
Dr. Lawrence John Severino, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 200 Saxon Woods Rd, White Plains, NY 10605 Phone: 914-949-6344 Fax: 914-948-5563 |